NLM Digital Collections

Search

Start Over Formats Text ✖Remove constraint Formats: Text Subjects Drugs, Generic -- economics ✖Remove constraint Subjects: Drugs, Generic -- economics

11. Rx price watch report: trends in retail prices of specialty prescription drugs widely used by Medicare beneficiaries : 2005 to 2009

Publication:
Washington, D.C. : AARP Public Policy Institute, c2012
Subject(s):
Drug Costs -- trends
Medicare Part D -- economics
Prescription Drugs -- economics
Drug Costs -- statistics & numerical data
Drugs, Generic -- economics
Forecasting
Pharmaceutical Preparations -- economics
Humans
United States

13. Generic drugs: Stakeholder views on improving FDA’s information on patents : report to congressional committees

Publication:
Washington, DC : United States Government Accountability Office, March 2023
Subject(s):
Drugs, Generic -- economics
Drug Development -- legislation & jurisprudence
Government Regulation
Legislation, Medical
Patents as Topic -- legislation & jurisprudence
Prescription Fees -- legislation & jurisprudence
United States

15. A sense of déjà vu: the debate surrounding state biosimilar substitution laws

Author(s):
Purvis, Leigh, author
Publication:
Washington, D.C. : AARP Public Policy Institute, September 2014
Subject(s):
Biological Products -- economics
Biological Products -- therapeutic use
Biosimilar Pharmaceuticals -- economics
Biosimilar Pharmaceuticals -- therapeutic use
Drug Costs
Drug Substitution
Legislation, Drug
Drugs, Generic -- economics
Federal Government
State Government
Humans
United States
United States. Food and Drug Administration.
United States.